ProfileGDS4718 / 1558653_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 17% 14% 17% 9% 10% 15% 17% 6% 16% 14% 9% 14% 15% 17% 66% 16% 10% 16% 15% 18% 12% 15% 8% 15% 8% 10% 8% 8% 28% 77% 19% 8% 12% 18% 13% 62% 14% 12% 14% 17% 7% 18% 14% 15% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0328617
GSM549102patient 115, normal, homogenized [OPG study]3.9219414
GSM549104patient 119, normal, homogenized [OPG study]4.0143217
GSM549108patient 138, normal, homogenized [OPG study]3.769859
GSM549119patient 077, normal, homogenized [OPG study]3.7985510
GSM549133patient 032, cancer, homogenized [OPG study]3.9232515
GSM549139patient 042, cancer, homogenized [OPG study]4.015117
GSM549099patient 107, normal, homogenized [OPG study]3.633076
GSM549109patient 139, normal, homogenized [OPG study]4.0132216
GSM549110patient 046, normal, homogenized [OPG study]3.9152114
GSM549114patient 063, normal, homogenized [OPG study]3.714959
GSM549122patient 082, normal, homogenized [OPG study]3.9520714
GSM549134patient 033, cancer, homogenized [OPG study]3.9549915
GSM549136patient 036, cancer, homogenized [OPG study]3.9972117
GSM549140patient 044, cancer, homogenized [OPG study]6.5729666
GSM549111patient 047, normal, homogenized [OPG study]3.9681516
GSM549113patient 057, normal, homogenized [OPG study]3.7522610
GSM549132patient 031, cancer, homogenized [OPG study]3.9873316
GSM549137patient 038, cancer, homogenized [OPG study]3.9620915
GSM549142patient 047, cancer, homogenized [OPG study]4.1571918
GSM549100patient 110, normal, homogenized [OPG study]3.8703712
GSM549107patient 135, normal, homogenized [OPG study]3.9453315
GSM549115patient 068, normal, homogenized [OPG study]3.66948
GSM549116patient 072, normal, homogenized [OPG study]3.9395815
GSM549120patient 078, normal, homogenized [OPG study]3.683568
GSM549131patient 030, cancer, homogenized [OPG study]3.7407210
GSM549118patient 074, normal, homogenized [OPG study]3.707948
GSM549129patient 027, cancer, homogenized [OPG study]3.716488
GSM549123patient 088, normal, homogenized [OPG study]4.4351928
GSM549124patient 006, cancer, homogenized [OPG study]7.471577
GSM549126patient 015, cancer, homogenized [OPG study]4.0824219
GSM549128patient 025, cancer, homogenized [OPG study]3.698128
GSM549103patient 117, normal, homogenized [OPG study]3.8864912
GSM549117patient 073, normal, homogenized [OPG study]4.0760618
GSM549138patient 041, cancer, homogenized [OPG study]3.8859613
GSM549141patient 045, cancer, homogenized [OPG study]6.27762
GSM549130patient 028, cancer, homogenized [OPG study]3.9468814
GSM549101patient 111, normal, homogenized [OPG study]3.8419712
GSM549105patient 128, normal, homogenized [OPG study]3.9342414
GSM549106patient 134, normal, homogenized [OPG study]3.9907717
GSM549112patient 048, normal, homogenized [OPG study]3.682287
GSM549125patient 011, cancer, homogenized [OPG study]4.0923818
GSM549127patient 024, cancer, homogenized [OPG study]3.8932414
GSM549135patient 035, cancer, homogenized [OPG study]3.9161215